Ledger.Open graph →
SEC Form D · filed July 2, 2014

Bellerophon Therapeutics LLC

Offering
$1
Sold
$1
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
HAMPTON, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

David D. Ritter · Atlanta, GADirectorDavid R. Emerson · Atlanta, GADirectorScott M. Freeman · Atlanta, GADirectorJohn W. Burgin · Atlanta, GADirectorJames Huff · Juno Beach, FLDirectorAlexander Weiss · Juno Beach, FLExecSteven R. Major · New York, NYDirectorJay R. Petschek · NEW YORK, NYExecLeo Lagrotte · Carmel, INExecDavid W. Freelove · New York, NYExecJonathan Abodeely · Burlington, VTDirectorJonathan Peacock · Thousand Oaks, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗